SARS-CoV-2 3CLpro-IN-16 structure
|
Common Name | SARS-CoV-2 3CLpro-IN-16 | ||
|---|---|---|---|---|
| CAS Number | 352659-40-6 | Molecular Weight | 294.37 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C17H14N2OS | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of SARS-CoV-2 3CLpro-IN-16SARS-CoV-2 3CLpro-IN-16 (Compound 3a) is a covalent SARS-CoV-2 3CLpro inhibitor (IC50s: 2.124 μM). SARS-CoV-2 3CLpro-IN-16 binds to the active site and forms a covalent bond with Cys145 of 3CLpro[1]. |
| Name | SARS-CoV-2 3CLpro-IN-16 |
|---|
| Description | SARS-CoV-2 3CLpro-IN-16 (Compound 3a) is a covalent SARS-CoV-2 3CLpro inhibitor (IC50s: 2.124 μM). SARS-CoV-2 3CLpro-IN-16 binds to the active site and forms a covalent bond with Cys145 of 3CLpro[1]. |
|---|---|
| Related Catalog | |
| Target |
2.124 μM (SARS-CoV-2 3CLpro)[1] |
| References |
| Molecular Formula | C17H14N2OS |
|---|---|
| Molecular Weight | 294.37 |